Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement pursuant to Regulation 47 of LODR Regulations, 2015 for unaudited results of quarter ended 31st December, 2023.14-02-2024
14-02-2024
Medico Remedies Ltd - 540937 - Outcome Of Board Meeting Held Today
Unaudited Financial Results for quarter and nine months ended 31st December, 202312-02-2024
Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of Board Meeting Held Today
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 12 February, 2024 has, inter alia considered and approved the Quarterly Unaudited Standalone Financial Results of the Company for the Quarter and Nine Months ended 31*'' December, 2023 along with the Limited Review Report thereon. (enclosed)12-02-2024
Medico Remedies Ltd - 540937 - Board Meeting Intimation for Consider And Approve, Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2023 Along With The Limited Review Report Thereon
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve Unaudited Financial Results for the Quarter and Nine months ended 31st December, 2023 along with the Limited Review Report thereon30-01-2024
Medico Remedies Ltd - 540937 - Submission Of Report Under Regulation 10(7) Of SAST Regulations
Report under Regulation 10(7) of SAST Regulations16-01-2024
Medico Remedies Ltd - 540937 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Harshit Haresh Mehta & Others16-01-2024
Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 read with Part A of SEBI (LODR) Regulations, 2015, please find enclosed herewith Investor Presentation for Q2 FY 23-24 of the Company.11-01-2024
Medico Remedies Ltd - 540937 - Submission Of Disclosure Of Inter-Se Transfer Of Shares Between The Promoter/Promoter Group Pursuant To Regulation 10(6) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
In terms of Reg 10(6) of SAST Regulations, 2011, we hereby enclose disclosure submitted by Mr. Harshit Mehta and Mr. Rishit Mehta with regards to acquisition of equity shares of the Company by way of off market inter-se transfer pursuant to executed gift deed.10-01-2024
Medico Remedies Ltd - 540937 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
In terms of Regulation 29(2) of SAST Regulations, 2011, we hereby enclose disclosure submitted by Mr. Haresh Mehta with regards to transfer of equity shares of the Company by way of off market inter-se transfer pursuant to executed gift deed.10-01-2024
Medico Remedies Ltd - 540937 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
In terms of Reg 29(2) of SAST Regulations, 2011, we hereby enclose disclosures submitted by Mr. Harshit Mehta and Mr. Rishit Mehta with regards to acquisition of equity shares of the Company by way of off market inter-se transfer pursuant to executed gift deed.10-01-2024